Reuters logo
BRIEF-St. Jude and Abbott to divest two businesses to Terumo Corp
October 18, 2016 / 12:47 PM / a year ago

BRIEF-St. Jude and Abbott to divest two businesses to Terumo Corp

Oct 18 (Reuters) - Abbott Laboratories -

* St. Jude Medical and Abbott to sell portion of vascular closure and electrophysiology businesses to Terumo Corporation

* Deal for purchase price of approximately $1.12 billion

* Abbott, St. Jude Medical and Terumo are bound by terms of an exclusivity agreement

* Divestiture is an all-cash transaction

* Abbott expects to mitigate any impact to its adjusted earnings per share projections related to sale of these assets to Terumo

* Abbott to retain vascular closure products

* Transaction is subject to successful completion of Abbott’s acquisition of St. Jude Medical and antitrust regulatory approvals Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below